The Journal of Organic Chemistry
Article
128.5, 127.2, 127.2, 126.9, 126.9, 125.2, 124.8, 40.2, 40.0, 25.8; HRMS
(ESI) m/z calcd for C26H23 335.1800 [M + H]+, found 335.1804.
(1R,4R)-2-(Naphthalen-1-yl)-5-phenylbicyclo[2.2.2]octa-2,5-
diene (5h). Phenyl ketone 2 (1.25 g, 6.3 mmol) was reacted with 1-
naphthylmagnesium bromide (0.25 M in THF) according to general
method A1 for 16 h. After aqueous workup, the crude product (2.8 g,
136%) was purified by chromatography on silica gel (7 g, eluent
heptane/EtOAc 9:1) to obtain crude tert-alcohol (1.45 g, 75%).
Another run starting with phenyl ketone 5h (1.25 g) gave crude tert-
alcohol (0.75 g, 39%). Both batches were combined (2.2 g) and
reacted with MsCl and Et3N according to general method A2 for 5 h
to afford crude 5h as beige oil (crude: 2.5 g, 64%). The crude product
was purified by chromatography on silica gel (25 g, eluent heptane), to
purified by chromatography on silica gel (40 g, eluent heptane) to
yield a fraction (2.29 g) that was purified again by chromatography on
silica gel (30 g, eluent heptane) to afford 5j as colorless oil (0.28 g,
4%): GC−MS 94.3% a/a, tR = 3.66 min, [M + 1]+ = 295; purity (LC−
MS) 100% a/a, tR = 2.11 min; chiral HPLC (Chiralpak IA, 250 × 4.6
ID, 5 μm, heptane/EtOH 9:1, 0.8 mL/min) er >99.5:0.5, tR = 7.2 min
1
(R,R), (tR = 11.4 min (S,S)); H NMR (CDCl3) δ 7.44−7.48 (m, 2
H), 7.33−7.40 (m, 2 H), 7.22−7.30 (m, 1 H), 6.93−7.00 (m, 2 H),
6.62−6.75 (m, 3 H), 4.28 (dd, J1 = 6.5 Hz, J2 = 1.8 Hz, 1 H), 4.16 (dd,
J1 = 6.0 Hz, J2 = 1.4 Hz, 1 H), 1.53−1.62 (m, 4 H); 13C NMR
(CDCl3) δ 163.3 (dd, J1 = 247 Hz, J2 = 14 Hz), 146.7, 145.2 (t, J = 3
Hz), 141.5 (t, J = 10 Hz), 137.9, 131.8, 128.7, 128.6, 127.0, 124.8,
107.5 (dd, J1 = 18 Hz, J2 = 7 Hz), 101.9 (t, J = 26 Hz), 40.2, 39.9, 25.7,
25.5; HRMS (ESI) m/z calcd for C20H16F2: 295.1298 [M + H]+,
found 295.1303. After storage at −20 °C for 8 months, the sample had
degraded, purity (LC−MS): 80.4% a/a.
afford 5h as colorless resin (1.16 g, 30%): [α]25 = +83.4 (c = 1.00,
D
CHCl3); GC−MS 98.5% a/a, tR = 4.73 min, [M + 1]+ = 309; purity
(LC−MS) 100% a/a, tR = 2.24 min, [M + 1]+ = 309; chiral HPLC
(Chiralpak AD-H, 250 × 4.6 ID, 5 μm, heptane/EtOH 1:1, 0.8 mL/
min) er >99.5:0.5, tR = 4.9 min (R,R), (tR = 4.6 min (S,S)); 1H NMR
(CDCl3) δ 7.94−8.00 (m, 1 H), 7.84−7.90 (m, 1 H), 7.76−7.81 (m, 1
H), 7.54−7.60 (m, 2 H), 7.37−7.53 (m, 5 H), 7.25−7.36 (m, 2 H),
6.85 (dd, J1 = 6.3 Hz, J2 = 2.0 Hz, 1 H), 6.54 (dd, J1 = 6.3 Hz, J2 = 1.9
Hz, 1 H), 4.31−4.36 (m, 1 H), 4.01−4.06 (m, 1 H), 1.52−1.78 (m, 4
H); 13C NMR (CDCl3) δ 147.4, 147.3, 138.7, 138.4, 133.9, 132.3,
131.7, 129.2, 128.6, 128.3, 127.3, 126.9, 126.2, 125.8, 125.7, 125.4,
125.0, 124.9, 44.2, 40.1, 25.9; HRMS (ESI) m/z calcd for C24H21
309.1643 [M + H]+, found 309.1640.
(1R,4R)-5-Phenylbicyclo[2.2.2]octa-2,5-dien-2-yl Trifluoro-
methanesulfonate (6). n-Butyllithium in hexane (1.6 M, 70.3 mL,
1.5 equiv) was added to diisopropylamine (11.6 mL, 1.5 equiv) at −78
°C in THF (25 mL). The mixture was warmed to −20 °C and stirred
at −20 °C for 10 min. After the mixture was cooled to −78 °C, a
solution of phenyl ketone 2 (15 g, 75.7 mmol) in THF (44 mL) was
added at −78 °C. After the mixture was stirred at −78 °C for 1 h, a
solution of 1,1,1-trifluoro-N-(pyridin-2-yl)-N-((trifluoromethyl)-
sulfonyl)methanesulfonamide27 (40.6 g, 1.5 equiv) in THF (44 mL)
was added. The brown solution was allowed to warm to rt. LC−MS
indicated >99% conversion. Cold water (200 mL) was added, and
THF was removed under reduced pressure at 50 °C. The mixture was
extracted with TBME (500 mL). The organic phase was washed with
10% aqueous NaOH solution (600 mL) and water (190 mL) and
evaporated to dryness under reduced pressure at 50 °C to afford the
crude product 6 as dark-red resin (crude: 33 g, 132%). The crude
product was purified by plug filtration over silica gel (190 g) using
heptane/EtOAc 9:1, fraction size approximately 100 mL, to afford
crude 6 as yellow oil (22 g, 88%): [α]25D = −5.90 (c = 1.10, CHCl3);
purity (LC−MS) 98.6% a/a, tR = 2.02 min; 1H NMR δ 7.20−7.52 (m,
5 H), 6.57 (dd, J1 = 6.4 Hz, J2 = 2.1 Hz, 1 H), 6.19 (dd, J1 = 7.2 Hz, J2
= 2.7 Hz, 1 H), 4.20 (m, 1 H), 3.76 (m, 1 H), 1.42−1.96 (m, 4 H);
13C NMR (CDCl3) δ 155.1, 147.0, 137.1, 128.6, 127.5, 127.3, 124.9,
(1R,4R)-2-(Naphthalen-2-yl)-5-phenylbicyclo[2.2.2]octa-2,5-
diene (5i). For the preparation of the 2-naphthyl Grignard reagent,
magnesium (1.22 g, 50.4 mmol) in THF (10 mL) was treated with a
solution of 2-bromonaphthalene (2.07 g, 10.1 mmol, 2 equiv) in THF
(10 mL). A slight exotherm was observed, and the mixture became
turbid. Additional THF (20 mL) was added, and the mixture was
stirred at rt for 15 min. The 2-naphthyl Grignard solution was cooled
to 0 °C, and a solution of phenyl ketone 2 (er >99.5:0.5, 1.0 g, 5.04
mmol, 1 equiv) in THF (10 mL) was added such that the temp did
not exceed 15 °C. The reaction mixture was stirred at rt for 2 h. The
reaction was quenched by addition of water (10 mL), the mixture was
extracted twice with TBME (2 × 10 mL), and the combined organic
phases were washed with water, dried over MgSO4, filtered, and
evaporated to dryness under reduced pressure to afford the tert-alcohol
as red viscous oil (2.53 g, 120%). The crude intermediate was
dissolved in CH2Cl2 (60 mL), and Et3N (5.4 mL, 38.8 mmol) was
added. MsCl (1.6 mL, 20.2 mmol) was added at 5 °C over 20 min. A
slight exotherm was observed, and the reaction mixture turned brown-
red. The reaction mixture was stirred at rt for 16 h. Water (50 mL) was
added, and the organic phase was washed with water (3×), dried over
MgSO4, filtered, and evaporated to dryness under reduced pressure to
yield crude 5i (crude: 1.8 g, 116%). Purification by chromatography
(50 g silica gel, ⌀ 3 cm, eluent heptane → heptane/EtOAc 10:2)
afforded 5i as off-white solid (810 mg, 52%). For analytical purposes, a
sample (750 mg) was further purified by crystallization from heptane
to give 5i as white solid (210 mg, 28% recovery): mp 119−121 °C;
120.3, 117.0, 40.7, 39.6, 25.8, 24.7; HRMS (ESI, negative mode) m/z
calcd for C15H13O3F3S 329.0459 [M − H]−, found 329.0463.
(1R,4R)-2-Methyl-5-phenylbicyclo[2.2.2]octa-2,5-diene (7a).
Methylmagnesium bromide (3 M in Et2O, 4 mL, 2.00 equiv) was
added with cooling to a mixture of triflate 6 (2 g, 6.05 mmol) and
iron(III) acetylacetonate (0.106 g, 0.05 equiv) in THF (30 mL) at
22−30 °C. The mixture was stirred at 35−40 °C for 3 d. Additional
iron(III) acetylacetonate (0.32 g, 0.15 equiv) and methylmagnesium
bromide (3 M in Et2O, 12 mL, 6.00 equiv) were added, and the
mixture was stirred at 30−40 °C for 24 h. GC−MS showed 81%
conversion. Water (20 mL) was added with cooling, followed by
TBME (50 mL). The organic phase was concentrated to dryness
under reduced pressure at 50 °C to afford crude 7a (crude: 1.3 g,
109%): purity (LC−MS) 96.8% a/a, tR = 2.0 min. The crude product
was purified by chromatography on silica gel (4 g, eluent heptane), to
[α]25 = +65.4 (c = 1.00, CHCl3); TLC Rf (heptane) = 0.19; Rf
D
(heptane/EtOAc 10:2) = 0.63; purity (LC−MS) 100% a/a, tR = 2.08
min, [M + 1]+ = 309; chiral HPLC (Chiralpak IA, 250 × 4.6 i.d., 5 μm,
heptane/EtOH 9:1, 0.8 mL/min) er >99.5:0.5, tR = 5.8 min (R,R) (tR
= 6.9 min (S,S)); 1H NMR (300 MHz, CDCl3) δ 7.70−7.90 (m, 4 H),
7.55−7.60 (m, 2 H), 7.2−7.50 (m, 6 H), 6.80 (dd, J1= 3 Hz, J2 = 6 Hz,
1 H), 6.70 (dd, J1 = 3 Hz, J2 = 6 Hz, 1 H), 4.41 (d, J = 6 Hz, 1 H), 4.29
(d, J = 6 Hz, 1 H), 1.61 (s br, 4 H); 13C NMR (300 MHz, CDCl3) δ
129.9, 129.2, 128.5, 128.1, 127.6, 126.8, 126.1, 125.5, 124.8, 123.7,
122.8, 41.2, 39.9, 25.9, 25.8; HRMS (ESI) m/z calcd for C24H21
309.1643 [M + H]+, found 309.1637.
(1R,4R)-2-(3,5-Difluorophenyl)-5-phenylbicyclo[2.2.2]octa-
2,5-diene (5j). Phenyl ketone 2 (5 g, 25.2 mmol) was reacted with
3,5-difluorophenylmagnesium bromide (0.5 M in THF) according to
general method A1 for 105 min. After aqueous workup, the crude tert-
alcohol was obtained (8.7 g, 110%); 8.15 g thereof was reacted with
MsCl and Et3N according to general method A2 for 70 min to afford
crude 5j as red-brown oil (crude: 8.5 g, 122%). The crude product was
afford 7a as colorless oil (0.54 g, 45%): [α]25 = −20.7 (c = 1.11,
D
CHCl3); purity (LC−MS) 98.8% a/a, [M + 1]+ = 197; chiral HPLC
(Chiralpak AD-H, 250 × 4.6 i.d., 5 μm, heptane/EtOH 1:1, 0.8 mL/
min) er >99.5:0.5, tR = 4.4 min, (tR = 4.7 min (S,S)); 1H NMR
(CDCl3) δ 7.42−7.46 (m, 2 H), 7.30−7.37 (m, 2 H), 7.19−7.25 (m, 1
H), 6.56 (dd, J1 = 6.3 Hz, J2 = 1.9 Hz, 1 H), 4.00−4.04 (m, 1 H),
3.45−3.49 (m, 1 H), 1.87 (s, 3 H), 1.40−1.49 (m, 4 H); 13C (CDCl3)
δ 147.0, 144.4, 138.5, 129.0, 128.4, 126.7, 126.6, 124.7, 43.1, 39.5, 26.2,
25.1, 19.3; HRMS (ESI) m/z calcd for C15H17 197.1330 [M + H]+,
found 197.1326.
(1R,4R)-2-Benzyl-5-phenylbicyclo[2.2.2]octa-2,5-diene (7b).
Benzylmagnesium bromide (19% in THF, 12 mL, 2.00 equiv) was
added to a mixture of triflate 6 (1.9 g, 5.75 mmol) and
iron(III)acetylacetonate (200 mg, 0.05 equiv) in THF (35 mL) at
35−40 °C. After 20 min of stirring at 33−40 °C, LC−MS indicated
>99% conversion. Water (40 mL) was added with cooling, followed by
4771
dx.doi.org/10.1021/jo3005638 | J. Org. Chem. 2012, 77, 4765−4773